Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Direct genetic test for glucocorticoid-remediable aldosteronism

Direct genetic test for glucocorticoid-remediable aldosteronism

US Patent 5529900 · Granted Jun 25, 1996

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Loss of function mutations in KCNJ10 cause SeSAME, a human syndrome with sensory2024
Compositions and methods for diagnosing and treating diseases and disorders asso2022
Loss of function mutations in KCNJ10 cause SeSAME, a human syndrome with sensory2020
Methods for identifying subjects with a genetic risk for developing IgA nephropa2019
Compositions and methods for assessing and treating adrenal diseases and disorde2018
Loss of function mutations in KCNJ10 cause SeSAME, a human syndrome with sensory2017
Methods for identifying subjects with a genetic risk for developing IgA nephropa2017
Assays for detecting WDR62 mutations2016
Drug screening and diagnosis based on paracrine tubular renin-angiotensin system2010
Method to diagnose and treat pathological conditions resulting from deficient io2003
Drug screening and diagnosis based on paracrine tubular renin-angiotensin system2002
Method to determine predisposition to hypertension2001